Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. Is Enact Holdings, Inc. (ACT) one of those stocks right now? Let's take a closer look at the stock's yearto-date performance to find out. Enact Holdings, Inc. is one of 859 companies in the Finance group. The Finance group currently sits at #5 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the in ...

Core Viewpoint - The expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act is a significant step towards the completion of the all-stock combination of Primo Water Corporation and BlueTriton Brands, Inc., expected to close by the end of 2024, pending other customary closing conditions [1]. Company Overview - Primo Water Corporation is a leading North America-focused provider of water solutions, operating primarily under a recurring revenue model in the large format water category, which includes products of 3 gallons or greater [3]. - The company's business strategy is likened to a "razor-razorblade" model, where the initial sale of water dispensers leads to ongoing purchases of water solutions [3]. - Primo Water's offerings include Water Direct, Water Exchange, and Water Refill, with a significant retail presence across approximately 11,350 locations for dispensers and 17,950 locations for water exchange services [3][4]. BlueTriton Overview - BlueTriton Brands, Inc. is a North American water and beverage company that produces and distributes a variety of spring and purified water brands, including Poland Spring and Deer Park [5]. - The company operates ReadyRefresh, a home and office beverage delivery platform that emphasizes reusable packaging, contributing to sustainability efforts [6]. - BlueTriton manages over 20,000 acres of watershed and has rights to collect water from more than 50 active spring sites, with 30 production facilities across North America [7]. Strategic Importance of the Transaction - The combination of Primo Water and BlueTriton is expected to enhance consumer access to purified and sustainable water solutions, promoting healthier lifestyles while reducing plastic waste [4]. - The transaction is anticipated to create synergies and improve operational efficiencies, although specific details on these benefits are not disclosed [1].

RALEIGH, N.C., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact), a leading provider of private mortgage insurance through its insurance subsidiaries, today addressed the updated Private Mortgage Insurer Eligibility Requirements (PMIERs) released by Fannie Mae and Freddie Mac (the GSEs), and the Federal Housing Finance Administration (FHFA) on August 21, 2024 which will be phased-in between March 31, 2025 and September 30, 2026. “The changes to the PMIERs requirements, which were ...

Toronto, Ontario--(Newsfile Corp. - Le 19 août/August 2024) - Aduro Clean Technologies Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every three and one quarter (3.25) pre-consolidated common shares. As a result, the outstanding shares of the company will be reduced to approximately 27,174,297 common shares. The name and symbol will not change. Please note that all open orders will be canceled at the close of ...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:GormanRupp (GRC) : This company which designs, manufactures and sells pumps and related equipment, has seen the Zacks Consensus Estimate for its current year earnings increasing 11.5% over the last 60 days.Hagerty (HGTY) : This company which offer automotive lifestyle brand and specialty insurance provider focused on automotive enthusiast market, has seen the Zacks Consensus Estimate for its current year earnings increasing 9.5% over th ...

Enact Holdings, Inc. (NASDAQ:ACT) Q2 2024 Earnings Conference Call August 1, 2024 8:00 AM ET Company Participants Daniel Kohl - VP, Investor Relations Rohit Gupta - President, Chief Executive Officer and Director Dean Mitchell - Executive Vice President, Chief Financial Officer, and Treasurer Conference Call Participants Soham Bhonsle - BTIG Rick Shane - JPMorgan Mihir Bhatia - Bank of America Geoffrey Dunn - Dowling Operator Good day, and thank you for standing by. Welcome to the Enact’s Q2 2024 Earnings C ...

Financial Performance - Total revenues for Q2 2024 were $298,834, an increase of 7.5% compared to $277,522 in Q2 2023[14] - Net income for Q2 2024 was $183,673, representing a 9.1% increase from $168,020 in Q2 2023[16] - Premiums earned in Q2 2024 were $244,567, up from $238,520 in Q2 2023, reflecting a growth of 2.2%[14] - Net investment income increased to $59,773 in Q2 2024, compared to $50,915 in Q2 2023, marking a rise of 17.4%[14] - The company reported a total comprehensive income of $184,845 for Q2 2024, compared to $143,019 in Q2 2023, an increase of 29.3%[16] - Net income for the six months ended June 30, 2024, was $344,661, compared to $344,008 for the same period in 2023, reflecting a slight increase[26] - Net cash provided by operating activities increased to $331,996 for the six months ended June 30, 2024, from $287,185 in 2023, representing a growth of approximately 15.6%[26] - Net investment income for the six months ended June 30, 2024, was $116,884, up from $96,256 in 2023, indicating a year-over-year increase of about 21.5%[34] - For the six months ended June 30, 2024, net income available to common stockholders was $344.661 million, compared to $344.008 million for the same period in 2023[127] - Basic earnings per share for the six months ended June 30, 2024, was $2.18, an increase from $2.13 for the same period in 2023[127] Assets and Equity - Total assets as of June 30, 2024, were $6,349,372, up from $6,190,473 at the end of 2023, indicating a growth of 2.6%[12] - Total equity increased to $4,825,829 as of June 30, 2024, compared to $4,632,347 at the end of 2023, reflecting a growth of 4.2%[12] - Cash and cash equivalents at the end of the period increased to $699,035 as of June 30, 2024, from $691,416 at the end of June 2023[26] Stock Repurchase and Dividends - The company repurchased common stock worth $48,610 during Q2 2024[20] - The company repurchased common stock worth $98,334 during the six months ended June 30, 2024, compared to $63,435 in the same period of 2023, reflecting a significant increase of about 55%[26] - A quarterly cash dividend of $0.185 per share was paid in Q2 2024, up from $0.16 per share in Q2 2023[135] - As of June 30, 2024, $238.2 million remained available under the share repurchase program[134] Investment Performance - Unrealized investment losses on available-for-sale securities were $236,463 as of June 30, 2024, compared to $230,556 at the end of 2023, indicating a slight deterioration in investment performance[42] - The total fair value of fixed maturity securities available-for-sale was $5,331,345, with gross unrealized losses of $318,662[47] - The amortized cost of total investments as of June 30, 2024, was $5,644,893, reflecting a decrease in fair value compared to the previous period[47] - The total fair value of fixed maturity securities in an unrealized loss position was $4,195,578, with gross unrealized losses of $318,662 as of June 30, 2024[49] - The fair value of U.S. corporate fixed maturity securities was $2,723.7 million, with $2,476.5 million classified as Level 2 and $247.2 million as Level 3[81] - Approximately 89% of the fixed maturity securities portfolio was priced using third-party pricing services as of June 30, 2024[64] Liabilities and Borrowings - The carrying amount of long-term borrowings was $742.368 million, with a fair value of $749.880 million[98] - As of June 30, 2024, long-term borrowings totaled $742.368 million, a slight decrease from $745.416 million as of December 31, 2023[114] - The company issued $750 million in Senior Notes due 2029, with an interest rate of 6.25% per year, beginning on November 28, 2024[112] - The company redeemed all $750 million of its 6.5% senior notes due 2025 at a price of 101% of the principal amount, resulting in a loss on debt extinguishment of $10.9 million[115] - The company has a five-year unsecured revolving credit facility of $200 million, with the option to increase by an additional $100 million, maturing in June 2027[116] - The company is in compliance with all covenants of the revolving credit facility, which has remained undrawn through June 30, 2024[117] Loss Reserves and Insurance Operations - Loss reserves decreased to $508,138 as of June 30, 2024, from $518,191 at the end of 2023, a reduction of 1.9%[12] - The net loss reserves at the end of June 30, 2024, were $505.362 million, down from $516.221 million at the beginning of the period[102] - The gross loss reserves for domestic mortgage insurance decreased from $517.515 million at the beginning of the period to $506.710 million at the end of the period[102] - Losses and loss adjustment expenses (LAE) incurred related to the current accident year were $135.053 million, compared to $120.175 million for the same period in 2023[104] - The company recorded favorable reserve adjustments of $131 million primarily on prior accident year reserves due to improved cure performance of delinquencies[104] - The total incurred losses and LAE for the six months ended June 30, 2024, were $1.821 million, reflecting a decrease from the previous year[104] - The company operates through a single segment, focusing on residential mortgage guaranty insurance, with operations in all 50 states and the District of Columbia[31]

-       Newly issued U.S. patent augments Actinium's existing composition of matter patent coverage over Iomab-B and Iomab-ACT targeted radiotherapy conditioning programs-       Pertains to the use of Iomab-ACT with genetically engineered hematopoietic stem cells for treating non-malignant diseases including sickle cell disease, severe combined immunodeficiency disease, β-thalassemia and Fanconi's anemiaNEW YORK, Aug. 1, 2024 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or ...

Enact Holdings, Inc. (ACT) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $1.10 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 23.30%. A quarter ago, it was expected that this company would post earnings of $0.99 per share when it actually produced earnings of $1.04, delivering a surprise of 5.05%.Over the last four quarters, the compa ...

Exhibit 99.1 ENACT REPORTS SECOND QUARTER 2024 RESULTS AND ANNOUNCES QUARTERLY DIVIDEND _______________________________________ GAAP Net Income of $184 million, or $1.16 per diluted share Adjusted Operating Income of $201 million, or $1.27 per diluted share Return on Equity of 15.4% and Adjusted Operating Return on Equity of 16.9% Record Primary insurance in-force of $266 billion, a 3% increase from second quarter 2023 PMIERs Sufficiency of 169% or $2,057 million Book Value Per Share of $30.91 and Book Valu ...